Stroke specialists are vital in diagnosing and treating cerebrovascular accidents (strokes), aiming to minimize brain damage and restore function. Early intervention is key to preventing long-term disability, and stroke specialists use advanced imaging techniques like CT scans and MRIs to determine the type of stroke—whether ischemic or hemorrhagic. For ischemic strokes, stroke specialists may use thrombolytics or perform mechanical thrombectomy to remove clots and restore blood flow to the brain. Once the acute phase is managed, stroke specialists play a crucial role in rehabilitation, collaborating with physical, occupational, and speech therapists to help patients regain lost functions such as movement, speech, and cognitive abilities. In addition to direct care, stroke specialists are focused on secondary prevention, advising patients on lifestyle changes such as diet, exercise, and smoking cessation, and prescribing medications to control hypertension, diabetes, and cholesterol. These efforts help reduce the risk of subsequent strokes. Stroke specialists also work closely with neurologists, neurosurgeons, and rehabilitation teams to provide comprehensive care, ensuring patients receive personalized treatment plans tailored to their recovery needs. Their expertise not only enhances the immediate care of stroke patients but also helps improve long-term outcomes by reducing stroke recurrence and associated disabilities.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States